We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
+1.01%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$1.17B
AUM Growth
+$137M
Cap. Flow
+$273M
Cap. Flow %
23.33%
Top 10 Hldgs %
50.6%
Holding
152
New
28
Increased
32
Reduced
40
Closed
19

Top Buys

Rank Stock Value
1
ASRT
Assertio
ASRT
+$18.2M
2
CRMT icon
America's Car Mart
CRMT
+$13M
3
PTON icon
Peloton Interactive
PTON
+$12.7M
4
ZVRA icon
Zevra Therapeutics
ZVRA
+$11.5M
5
NDLS icon
Noodles & Co
NDLS
+$7.52M

Top Sells

Rank Stock Value
1
TBBK icon
The Bancorp
TBBK
+$14M
2
AUTL
Autolus Therapeutics
AUTL
+$10.2M
3
CASH icon
Pathward Financial
CASH
+$8.42M
4
MAX icon
MediaAlpha
MAX
+$8.11M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$6.53M

Sector Composition

Rank Sector Weight
1 Healthcare 36.11%
2 Consumer Discretionary 9.31%
3 Financials 6.27%
4 Communication Services 5.51%
5 Technology 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HGV icon
26
CALL
Hilton Grand Vacations
HGV
$3.31B
$10.2M 0.87%
+250,000
New +$11M
PAYO icon
27
Payoneer
PAYO
$2.4B
$9.87M 0.84%
1,612,862
– –
RDNW
28
RideNow Group
RDNW
$248M
$9.84M 0.84%
1,605,392
+334,041
+26% +$2.69M
ABEO icon
29
Abeona Therapeutics
ABEO
$425M
$9.67M 0.83%
2,297,794
+895,914
+64% +$3.39M
CDXS icon
30
Codexis
CDXS
$161M
$9.58M 0.82%
5,069,443
+33,780
+0.7% +$79K
AMRX icon
31
Amneal Pharmaceuticals
AMRX
$5.71B
$9.34M 0.8%
2,212,757
+63,452
+3% +$237K
NDLS icon
32
Noodles & Co
NDLS
$96M
$8.6M 0.73%
436,978
+311,978
+250% +$7.52M
HLF icon
33
CALL
Herbalife
HLF
$1.21B
$8.39M 0.72%
600,000
– –
MLKN icon
34
MillerKnoll
MLKN
$1.64B
$8.32M 0.71%
340,228
-267,655
-44% -$5.01M
TRML
35
DELISTED
Tourmaline Bio
TRML
$8.3M 0.71%
295,313
+150,310
+104% +$4.4M
DHX icon
36
DHI Group
DHX
$158M
$8.26M 0.71%
2,698,201
-331,997
-11% -$1.18M
DRIO icon
37
DarioHealth
DRIO
$74.7M
$7.92M 0.68%
120,710
-215
-0.2% -$14.5K
AMLX icon
38
Amylyx Pharmaceuticals
AMLX
$2.53B
$7.46M 0.64%
407,205
+242,705
+148% +$5.13M
ZM icon
39
CALL
Zoom
ZM
$31.4B
$6.99M 0.6%
100,000
– –
ILPT
40
Industrial Logistics Properties Trust
ILPT
$583M
$6.81M 0.58%
2,357,284
– –
AURA icon
41
Aura Biosciences
AURA
$796M
$6.67M 0.57%
743,892
-59,433
-7% -$639K
DXPE icon
42
DXP Enterprises
DXPE
$2.99B
$6.29M 0.54%
179,987
-33,685
-16% -$1.22M
DYN icon
43
Dyne Therapeutics
DYN
$4.95B
$6.12M 0.52%
683,164
+90,000
+15% +$969K
RDI icon
44
Reading International Class A
RDI
$35.2M
$6.1M 0.52%
2,876,040
-9,474
-0.3% -$23.2K
RSVR
45
Reservoir Media
RSVR
$656M
$6.02M 0.51%
+986,328
New +$5.53M
EHTH icon
46
eHealth
EHTH
$40.4M
$5.92M 0.51%
800,000
– –
NSPR icon
47
InspireMD
NSPR
$37.5M
$5.78M 0.49%
1,768,050
-92,355
-5% -$295K
ANTX icon
48
AN2 Therapeutics
ANTX
$213M
$5.74M 0.49%
+356,789
New +$4.04M
COGT icon
49
Cogent Biosciences
COGT
$7.1B
$5.61M 0.48%
575,000
+510,868
+797% +$6.06M
RH icon
50
RH
RH
$3.47B
$5.51M 0.47%
+20,853
New +$7.25M
1
2
3 4 5

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return

Nantahala Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Nantahala Capital Management held 152 positions worth $1.17B, up 13% from $1.03B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Nantahala Capital Management deployed $273M of net new capital in Q3 2023, opening 28 new positions and adding to 32 existing holdings. Its largest new stake was Assertio: 311,333 shares worth $12M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 41% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was The Bancorp, an estimated $14M trimmed.

  • Nantahala Capital Management's largest Q3 2023 buy was Assertio: 311,333 shares worth $12M.
  • Nantahala Capital Management added most to America's Car Mart in Q3 2023, an estimated $13M increase.
  • Nantahala Capital Management's biggest Q3 2023 reduction was The Bancorp, cutting an estimated $14M.
  • Nantahala Capital Management fully exited Autolus Therapeutics in Q3 2023, selling an estimated $10.2M.
  • Nantahala Capital Management's ten largest holdings make up 51% of its $1.17B portfolio in Q3 2023.
  • Nantahala Capital Management opened 28 new positions and closed 19 in Q3 2023.
  • Nantahala Capital Management's portfolio value rose 13% quarter-over-quarter to $1.17B.

Based on Nantahala Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.